The HIT-network for children and adolescents with CNS tumors facilitates improvements of diagnostic assessments, multimodal treatments, individual counselling, and research in Germany, Austria, and Switzerland
Stefan Rutkowski(Universität Hamburg), Johannes Gojo(Medical University of Vienna), Martin Benesch(St Nicholas Hospital), Christof M. Kramm(Universitätsmedizin Göttingen), Andreas Faldum(University of Münster), Dominik Sturm(German Cancer Research Center), Hermann L. Müller(Klinikum Oldenburg), Brigitte Bison(University of Augsburg), Christian Thomas(University Hospital Münster), Irene Slavc(Comprehensive Cancer Center Vienna), Christian Hagel(Universität Hamburg), Martin Hasselblatt(University Hospital Münster), Matthias Eyrich(University of Würzburg), Gudrun Fleischhack(Essen University Hospital), Mechthild Krause(Helmholtz-Zentrum Dresden-Rossendorf), Pablo Hernáiz Driever(Charité - Universitätsmedizin Berlin), Denise Obrecht(Universität Hamburg), David Capper(German Cancer Research Center), Pedram Emami(Universität Hamburg), Stefan M. Pfister(Heidelberg University), Monika Warmuth‐Metz, Astrid Gnekow(University Hospital Augsburg), Torsten Pietsch(University Hospital Bonn), Rolf‐Dieter Kortmann(University of Turin), Thomas Perwein(Medical University of Graz), Uwe Kordes(Universität Hamburg), Felix Sahm(German Cancer Research Center), Carsten Friedrich(Klinikum Oldenburg), Cécile M. Ronckers(Johannes Gutenberg University Mainz), Pascal D. Johann(University of Augsburg), Ulrich Schüller(Universität Hamburg), Karolina Nemes, Holger Ottensmeier(Universitätsklinikum Würzburg), Jürgen Debus(Heidelberg University), Michael Frühwald C(University Hospital Augsburg), Stephan Tippelt(Essen University Hospital), Stefan Schönberger(Essen University Hospital), David Jones(German Cancer Research Center), D Grabow(Johannes Gutenberg University Mainz), Jürgen Krauß(National Center for Tumor Diseases), Karen Dieckmann(Medical University of Vienna), Arend Koch(Charité - Universitätsmedizin Berlin), Fabian Pöhl(University of Regensburg), Olaf Witt(German Cancer Research Center), Rudolf Schwarz(Universität Hamburg), Wolf JEA(University of Regensburg), Martin U. Schuhmann(University Children's Hospital Tübingen), von Zezschwitz B(Charité - Universitätsmedizin Berlin), Petra Ketteler(Essen University Hospital)
Cited by 1
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
|The Lancet Neurology|2020|1.4k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k